Article thumbnail

Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans

By Jean-Baptiste Michel, José-Luis Martin-Ventura, Jesus Egido, Natzi Sakalihasan, Vladislav Treska, Jes Lindholt, Eric Allaire, Unnur Thorsteinsdottir, Gillian Cockerill and Jesper Swedenborg

Abstract

Aneurysm of the abdominal aorta (AAA) is a particular, specifically localized form of atherothrombosis, providing a unique human model of this disease. The pathogenesis of AAA is characterized by a breakdown of the extracellular matrix due to an excessive proteolytic activity, leading to potential arterial wall rupture. The roles of matrix metalloproteinases and plasmin generation in progression of AAA have been demonstrated both in animal models and in clinical studies. In the present review, we highlight recent studies addressing the role of the haemoglobin-rich, intraluminal thrombus and the adventitial response in the development of human AAA. The intraluminal thrombus exerts its pathogenic effect through platelet activation, fibrin formation, binding of plasminogen and its activators, and trapping of erythrocytes and neutrophils, leading to oxidative and proteolytic injury of the arterial wall. These events occur mainly at the intraluminal thrombus–circulating blood interface, and pathological mediators are conveyed outwards, where they promote matrix degradation of the arterial wall. In response, neo-angiogenesis, phagocytosis by mononuclear cells, and a shift from innate to adaptive immunity in the adventitia are observed. Abdominal aortic aneurysm thus represents an accessible spatiotemporal model of human atherothrombotic progression towards clinical events, the study of which should allow further understanding of its pathogenesis and the translation of pathogenic biological activities into diagnostic and therapeutic applications

Topics: Reviews
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:3058728
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2006). 99mTc-annexin-V functional imaging of luminal thrombus activity in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol
  2. A et al. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases.
  3. A meta-analysis of association between serum lipoproteins and abdominal aortic aneurysm.
  4. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm.
  5. Abdominal aortic aneurysm is a specific antigen-driven T cell disease.
  6. Abdominal aortic aneurysm.
  7. Abdominal aortic aneurysms, or a relatively large diameter of non-aneurysmal aortas, increase total and cardiovascular mortality: the Tromsø study.
  8. Accelerated replicative senescence of medial smooth muscle cells derived from abdominal aortic aneurysms compared to the adjacent inferior mesenteric artery.
  9. Acher CW et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms.
  10. (1996). Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms.
  11. Adrenomedullin in mast cells of abdominal aortic aneurysm.
  12. (2008). Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res
  13. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm.
  14. (2008). Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms. Atherosclerosis
  15. (1996). Angiogenesis in abdominal aortic aneurysms.
  16. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.
  17. (2006). Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet
  18. (1999). Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med
  19. (2010). Association between serum lipoproteins and abdominal aortic aneurysm.
  20. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening.
  21. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005;25: 2054–2061. Pathophysiology of abdominal aortic aneurysms 27
  22. Autoimmune aspects of chronic periaortitis.
  23. (2008). Bacterial signatures in atherosclerotic lesions represent human commensals and pathogens. Atherosclerosis
  24. (2009). Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol
  25. Bleeding into the intraluminal thrombus in abdominal aortic aneurysms is associated with rupture.
  26. (2004). C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation
  27. (1997). Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm.
  28. (2003). Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis
  29. Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin.
  30. Chlamydial lipopolysaccharide (cLPS) is present in atherosclerotic and aneurysmal arterial wall—cLPS levels depend on disease manifestation.
  31. (2009). Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation
  32. (1980). Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms. Arch Surg
  33. (1994). Computed tomography scanning findings associated with rapid expansion of abdominal aortic aneurysms.
  34. (2001). Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction. Arterioscler Thromb Vasc Biol
  35. Contribution of cell surface protein antigen c of Streptococcus mutans to platelet aggregation.
  36. Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms.
  37. Cystatin C deficiency in human atherosclerosis and aortic aneurysms.
  38. Cysteine protease activity in the wall of abdominal aortic aneurysms.
  39. (1994). Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis).
  40. (2000). Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med
  41. (1999). Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation
  42. (1997). Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms.
  43. Detection and localization of periodontopathic bacteria in abdominal aortic aneurysms.
  44. Detection of Actinobacillus actinomycetemcomitans but not bacteria of the red complex in aortic aneurysms by multiplex polymerase chain reaction.
  45. Detection of C. pneumoniae by polymerase chain reaction-enzyme immunoassay in abdominal aortic aneurysm walls and its association with rupture.
  46. Detection of oral bacteria in cardiovascular specimens.
  47. Determination of the expansion rate and incidence of rupture of abdominal aortic aneurysms.
  48. Different disease profiles for women and men with abdominal aortic aneurysms.
  49. Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus.
  50. Discontinuous, staccato growth of abdominal aortic aneurysms.
  51. (2009). Discovery of the role of wall shear in atherosclerosis. Arterioscler Thromb Vasc Biol
  52. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology.
  53. Doxycycline therapy for abdominal aneurysm: improved proteolytic balance through reduced neutrophil content.
  54. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.
  55. (1991). Effects of hypertension on aortic antioxidant status in human abdominal aneurysmal and occlusive disease. Proc Soc Exp Biol Med
  56. (2005). Effects of pulsation frequency and endothelial integrity on enhanced arterial transmural filtration produced by pulsatile pressure.
  57. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases.
  58. (1997). Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol
  59. (2000). Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol
  60. (2009). Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med
  61. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur Heart J 2010; doi:10.1093/eurheartj/ehq171. Published online ahead of print 8
  62. Failure properties of intraluminal thrombus in abdominal aortic aneurysm under static and pulsating mechanical loads.
  63. Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms.
  64. Genetic and environmental contributions to abdominal aortic aneurysm development in a twin population.
  65. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm.
  66. Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm.
  67. Gradient of proteolytic enzymes, their inhibitors and matrix proteins expression in a ruptured abdominal aortic aneurysm.
  68. Haemostatic and fibrinolytic factors in men with a small abdominal aortic aneurysm.
  69. (2009). Haemostatic markers in patients with abdominal aortic aneurysm and the impact of aneurysm size. Thromb Res
  70. (2007). Hamsten A et al. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost
  71. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 2010;12:293–304.
  72. HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property.
  73. He A et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation.
  74. Hemorphin 7 reflects hemoglobin proteolysis in abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2010;30:269–275.
  75. Henriksson AE. Abdominal aortic aneurysm and the impact of infectious burden.
  76. High frequency of thoracic aneurysms in patients with abdominal aortic aneurysms. Ann Surg 2010; doi:10.1097/SLA.0b013e3181d96498. Published online ahead of print 21
  77. High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg 2010;39:295–301.
  78. High-attenuating crescent in abdominal aortic aneurysm wall at CT: a sign of acute or impending rupture.
  79. High-risk and low-risk screening for abdominal aortic aneurysm both reduce aneurysm-related mortality. A stratified analysis from a single-centre randomised screening trial.
  80. (1990). Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immunemediated response.
  81. (2007). Hyperimmunoglobulinemia E syndrome associated with coronary artery aneurysms: deficiency of central memory CD4+ T cells and expansion of effector memory CD4+ T cells. Ann Allergy Asthma Immunol
  82. IgG4-related disease: historical overview and pathology of hematological disorders.
  83. Immunoblotting analysis of abdominal aortic aneurysms using antibodies against Chlamydia pneumoniae recombinant MOMP.
  84. (2005). Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis
  85. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall.
  86. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008;48:417–423; discussion 424.
  87. Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution.
  88. (2002). Increased medial TUNEL-positive staining associated with apoptotic bodies is linked to smooth muscle cell diminution during evolution of abdominal aortic aneurysms. Ann Vasc Surg
  89. Inflammatory abdominal aortic aneurysm and the associated T-cell reaction: a case study.
  90. Inflammatory abdominal aortic aneurysm.
  91. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall.
  92. (2009). Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial. Vasc Endovasc Surg
  93. Intramural hematoma of the aorta: predictors of progression to dissection and rupture.
  94. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
  95. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.
  96. Long-term benefit and costeffectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial.
  97. (2008). Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovasc Surg
  98. Manolescu A et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm.
  99. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms.
  100. (2007). Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association. Connect Tissue Res
  101. (2009). Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res
  102. (2008). Medical management of small abdominal aortic aneurysms. Circulation
  103. Modeling of low-density lipoprotein (LDL) transport in the artery— effects of hypertension.
  104. (1998). Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms The UK Small Anurysm Trial Participants. Lancet
  105. MR imaging of iron phagocytosis in intraluminal thrombi of abdominal aortic aneurysms in humans.
  106. (1995). P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin.
  107. Pericellular plasmin induces smooth muscle cell anoikis.
  108. (1992). Phagocytosis of Porphyromonas gingivalis and Prevotella intermedia by human polymorphonuclear leukocytes in clots formed from human plasma or purified fibrinogen.
  109. Pharmacological treatment of abdominal aortic aneurysm.
  110. (2000). Plasma and tissue levels of collagen types I and III markers in patients with abdominal aortic aneurysms. Int Angiol
  111. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment.
  112. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes.
  113. (1997). Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions.
  114. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA).
  115. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture – a systematic review.
  116. (2005). Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol
  117. (2007). Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Immunol Rev
  118. (2007). Proteomics in atherothrombosis: a future perspective. Expert Rev Proteomics
  119. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.
  120. Regulation of smooth muscle cell growth, function and death in vitro by activated mast cells—a potential mechanism for the weakening and rupture of atherosclerotic plaques.
  121. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases.
  122. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.
  123. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus.
  124. (2007). Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol
  125. Rumley A et al. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
  126. Screening for abdominal aortic aneurysm reduces overall mortality in men. A meta-analysis of the mid- and long-term effects of screening for abdominal aortic aneurysms.
  127. Screening for abdominal aortic aneurysms: single centre randomised controlled trial.
  128. Screening men for abdominal aortic aneurysm: 10 year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study.
  129. (1992). Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway.
  130. Small Aneurysm Trial Participants. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms.
  131. Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic aneurysms.
  132. (1986). The anechoic crescent in abdominal aortic aneurysms: not a sign of dissection.
  133. The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms – a prospective randomized double-blind trial.
  134. The effects of recirculation flows on mass transfer from the arterial wall to flowing blood.
  135. Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms.
  136. Trans-thrombus blood pressure effects in abdominal aortic aneurysms.
  137. Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury.
  138. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components.
  139. Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms.
  140. Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm.